AU7394294A - Macrophage migration inhibitory factor-3 - Google Patents

Macrophage migration inhibitory factor-3

Info

Publication number
AU7394294A
AU7394294A AU73942/94A AU7394294A AU7394294A AU 7394294 A AU7394294 A AU 7394294A AU 73942/94 A AU73942/94 A AU 73942/94A AU 7394294 A AU7394294 A AU 7394294A AU 7394294 A AU7394294 A AU 7394294A
Authority
AU
Australia
Prior art keywords
inhibitory factor
macrophage migration
migration inhibitory
macrophage
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73942/94A
Other languages
English (en)
Inventor
Lisa M Fitzgerald
Haodong Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU7394294A publication Critical patent/AU7394294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU73942/94A 1994-05-16 1994-05-16 Macrophage migration inhibitory factor-3 Abandoned AU7394294A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/005385 WO1995031468A1 (fr) 1994-05-16 1994-05-16 Facteur-3 inhibiteur de la migration des macrophages

Publications (1)

Publication Number Publication Date
AU7394294A true AU7394294A (en) 1995-12-05

Family

ID=22242566

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73942/94A Abandoned AU7394294A (en) 1994-05-16 1994-05-16 Macrophage migration inhibitory factor-3

Country Status (4)

Country Link
EP (1) EP0770086A4 (fr)
JP (1) JPH10500301A (fr)
AU (1) AU7394294A (fr)
WO (1) WO1995031468A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US8212004B2 (en) 1999-03-02 2012-07-03 Human Genome Sciences, Inc. Neutrokine-alpha fusion proteins
WO2002002641A1 (fr) 2000-06-16 2002-01-10 Human Genome Sciences, Inc. Anticorps se liant de maniere immunospecifique a un stimulateur de lymphocyte b
US7879328B2 (en) 2000-06-16 2011-02-01 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to B lymphocyte stimulator
AU2001288301A1 (en) 2000-08-18 2002-03-04 Human Genome Sciences, Inc. Binding polypeptides and methods based thereon
WO2002020758A2 (fr) * 2000-09-05 2002-03-14 Curagen Corporation Nouvelles proteines et acides nucleiques codant pour ces proteines
EP1534752B1 (fr) 2002-05-01 2011-08-03 Human Genome Sciences, Inc. Anticorps a liaison specifique avec la chimiokine beta-4
US9168286B2 (en) 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
US8211649B2 (en) 2006-03-31 2012-07-03 Human Genome Sciences, Inc. Methods of diagnosing and prognosing hodgkin's lymphoma
EP2640744A4 (fr) 2010-11-19 2014-05-28 Eisai R&D Man Co Ltd Neutralisation d'anticorps anti-ccl20
JP2014530360A (ja) 2011-10-07 2014-11-17 バクスター・ヘルスケヤー・ソシエテ・アノニムＢａｘｔｅｒ Ｈｅａｌｔｈｃａｒｅ ＳＡ 診断マーカーとしてのｏｘＭＩＦ
WO2013184209A1 (fr) * 2012-06-04 2013-12-12 Ludwig Institute For Cancer Research Ltd. Mif destiné à être utilisé dans des méthodes de traitement de sujets atteints d'une maladie neurodégénérative

Also Published As

Publication number Publication date
JPH10500301A (ja) 1998-01-13
EP0770086A4 (fr) 1998-07-15
EP0770086A1 (fr) 1997-05-02
WO1995031468A1 (fr) 1995-11-23

Similar Documents

Publication Publication Date Title
AU6603396A (en) Attachment strips
AU3304795A (en) Bisresorcinyltriazines
AU4036895A (en) Substituted 1H-imidazoles
AU3304995A (en) 2-Hydroxyphenyltriazines
AU7394294A (en) Macrophage migration inhibitory factor-3
AU2837895A (en) Thiazine- or thiazepine-derivatives
AU4044795A (en) Handleset
AU2844595A (en) Substituted biphenyloxazolines
AU2308295A (en) Heterocyclylbenzonitriles
AU1963395A (en) Boom-structure
AU2634695A (en) Hull-related arrangement
AU4029295A (en) Thienopyridones
AU7469594A (en) Poop-scoop
AU4590996A (en) Boekomslag
AU2411395A (en) Hydrocopter
AU1603595A (en) Meso-azanoradamantanes
AU3446995A (en) Biodestumping
ZA943698B (en) Macrophage migration inhibitorz factor-3
AU3417395A (en) Hydro-ethano-indeno-pyridines
AU693187B2 (en) Engaging element
AU661263B3 (en) Rotakite
AU658811B3 (en) Bum-bag
AU693176C (en) Campervan
AUPM429094A0 (en) Holophotal array
AUPN023194A0 (en) Ladder rack